Zacks upgraded shares of Cambrex Corp. (NYSE:CBM) from a neutral rating to an outperform rating in a research note issued to investors on Thursday, American Banking and Market News reports. The firm currently has $20.10 price target on the stock. Cambrex Corporation (NYSE:CBM) stock opened at $18.16 in last trading session, and closed at $19.91, trading in the range of $18.10 – 20.50. The stock showed a positive/negative weekly performance of 0.58%.
Anika Therapeutics, Inc. (NASDAQ:ANIK) average recommendation is Buy with average Target Price of $43.50. Anika Therapeutics, Inc. (NASDAQ:ANIK) shares closed at $31.36 on last trade day, by gaining 6.38%. Stock 52 week range is $10.50 – $39.40. Company’s market capitalization is $433.57 billion.
BIND Therapeutics Inc (NASDAQ:BIND) average recommendation is buy with average Target Price of $25.25. BIND Therapeutics Inc (NASDAQ:BIND) stock advanced 7.72% and finished the last session at $12.56. The EPS of the stock remained -7.29. Company’s market capitalization is $205.58 billion.
Oncomed Pharmaceuticals (NASDAQ:OMED) had its price objective hosited by Piper Jaffray to $48.00 in a report released on Friday, American Banking and Market News reports. Oncomed Pharmaceuticals Inc (NASDAQ:OMED) stock opened at $28.70 in last trading session and closed at $30.35. The 52 week range of the stock is $12.06 – $42.34 and the day range was $28.70 – $31.14.
Leave a Reply